Document is current
Any future updates will be listed below
-
Authors
Yiallouros, Panayiotis K. http://orcid.org/0000-0002-8339-9285
Matthaiou, Andreas Μ.
Anagnostopoulou, Pinelopi
Kouis, Panayiotis
Libik, Malgorzata
Adamidi, Tonia
Eleftheriou, Adonis
Demetriou, Artemios
Ioannou, Phivos
Tanteles, George A.
Costi, Constantina
Fanis, Pavlos
Macek, Milan
Neocleous, Vassos
Phylactou, Leonidas A.
-
Funding
Funding for this research was provided by:
A.G. Leventis Foundation
Vertex Pharmaceuticals (CG-2015-1046430)
Czech Ministry of Health (IP00064203/6003)
Czech Ministry of Youth, Education and Sports (LM2018132, CZ.02.1.01/0.0/0.0/18_046/0015515)
- License Information
-
More Information
Article History
Received: 6 April 2021
Accepted: 19 September 2021
First Online: 2 October 2021
Declarations
:
: The establishment and operation of the Cyprus National Cystic Fibrosis Patient Registry, including the potential for use of all data from the Registry records for the purposes of epidemiological studies, has been approved by the Cyprus National Bioethics Committee (EEBK ΕΠ 2017.01.117). All cystic fibrosis patients in Cyprus, or their parents or legal guardians in the cases of patients below the age of 18 years, have given their written informed consent for their participation in the Registry and the potential for use of their data from the Registry records for the purposes of epidemiological studies.
: All cystic fibrosis patients in Cyprus, or their parents or legal guardians in the cases of patients below the age of 18 years, for whom separate case reports are included in the current study, have given their written informed consent for the publication of their individual data.
: The authors declare that they have no competing interests or financial relationships that might have influenced the present work.
